Harold S. Bernstein

The hypertrophic response in C2C12 myoblasts recruits the G1 cell cycle machinery.

Genome-wide examination of myoblast cell cycle withdrawal during differentiation.

Distinct domains of human CDC5 direct its nuclear import and association with the spliceosome.

E2F-1 regulates the expression of a subset of target genes during skeletal myoblast hypertrophy.

Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells.

CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.

Stem cell antigen-1 regulates the tempo of muscle repair through effects on proliferation of alpha7 integrin-expressing myoblasts.

MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.

Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts.

Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processing.

Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures.

Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology.

Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.

Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.

Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.

High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons.

Cardiac regeneration using human embryonic stem cells: producing cells for future therapy.

Letter by Lowenthal et al regarding article, "BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial".

An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors.

Treatment of pulmonary arterial hypertension with circulating angiogenic cells.

The promise of human embryonic stem cells in aging-associated diseases.

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Usefulness of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide as Biomarkers for Heart Failure in Young Children With Single Ventricle Congenital Heart Disease.

Sca-1 cardiosphere-derived cells are enriched for isl1-expressing cardiac precursors and improve cardiac function after myocardial injury.